The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
- Commercial/Private Labs
- Blood Banks
- Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 241 pages and 14 tables
SIMILAR MARKET STUDIES
Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Summary This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years.
November 2013 | $21100 | View Details >>
This 165-page report presents the clinical significance and market needs for major hemostasis laboratory tests, as well as extensive listings of companies developing or marketing innovative coagulation technologies and products. The report also includes strategic assessments of current and emerging suppliers of hemostasis diagnostic products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 165 pages and 19 tables
January 2014 | $0 | View Details >>
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA. This report mainly covers the Liquid Biopsy Products product type by technology?circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), ...
September 2016 | $3480 | View Details >>
This new report from VPGMarketResearch.com provides analysis of Occult Blood testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - ...
August 2015 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research